GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

umifenovir   Click here for help

GtoPdb Ligand ID: 11089

Synonyms: AR-1I9514 | Arbidol®
Approved drug PDB Ligand
umifenovir is an approved drug (Russia, China)
Compound class: Synthetic organic
Comment: Umifenovir is an indole-based antiviral drug. It is a viral entry inhibitor [3] and also acts to modulate the host immune response (induces interferon-production, stimulates macrophages phagocytosis).

umifenovir is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 80
Molecular weight 476.08
XLogP 5.1
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C
Isomeric SMILES CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C
InChI InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3
InChI Key KCFYEAOKVJSACF-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
No information available.
Summary of Clinical Use Click here for help
Umifenovir is used for the treatment and prophylaxis of influenza and other respiratory infections. It is currently under investigation as a potential treatment and prophylactic agent for COVID-19 (SARS-CoV-2 infection) in combination with both currently available and investigational HIV therapies.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04350684 Umifenovir in Hospitalized COVID-19 Patients Phase 4 Interventional Shahid Beheshti University of Medical Sciences
NCT04286503 The Clinical Study of Carrimycin on Treatment Patients With COVID-19 Phase 4 Interventional Beijing YouAn Hospital
NCT03787459 Severe Influenza Trial of ARbidol Phase 3 Interventional Capital Medical University